Patents Assigned to Klinkum der Albert-Ludwigs-Universitat Freiberg
  • Patent number: 5472867
    Abstract: Patients suffering from certain types of cancer are treated by high-dose chemotherapy. In order to allow a recovery a process for the ex vivo expansion of peripheral blood progenitor cells is described, wherein CD 34.sup.+ -cells are enriched and cultivated in a medium comprising IL-1, IL-3, IL-6, EPO and SCF. The ex vivo expanded peripheral blood progenitor cells can be administered to cancer patients after chemotherapy.
    Type: Grant
    Filed: September 29, 1993
    Date of Patent: December 5, 1995
    Assignee: Klinkum der Albert-Ludwigs-Universitat Freiberg
    Inventors: Lothar Kanz, Woefram Brugger, Roland Mestepsmann